Impact of heart failure on ischaemic preconditioning in humans

Impact of heart failure on ischaemic preconditioning in humans - IPC-HF

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37367

Enrollment

Registered

2012-04-18

Start date

2012-05-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Heart failure patients (NYHA-classification category II or III + ejection fraction of

Exclusion criteria

Exclusion criteria: - Smokers - Type I or II diabetes mellitus - Mild renal impairment or proteinuria - Hepatic impairment - Hypercholesterolaemia (>=6.5 mmol/L) - Hypertension - Atrial fibrillation - Pre-menopausal females or those on hormone replacement therapy - Other (serious) pathology, such as chronic obstructive pulmonary disease

Design outcomes

Primary

Measure	Time frame
Change in endothelial function after reperfusion injury	—

Countries

Netherlands

Outcome results